Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Lack of efficacy as add-on therapy to vancomycin to treat deep-seated MRSA infections in Phase II trial (development terminated) Lipoteichoic acid † Bacteria cell wall component Humanized ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

The resistance of some infections to effective treatment with existing antibiotics is allowing ... In 1962, the first case of methicillin-resistant Staphylococcus aureus (MRSA) was identified.

aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea. Ceftobiprole was turned down by the FDA in 2009 for ABSSSI, when the drug was partnered ...

Scientists who developed the Oxford AstraZeneca vaccine during the Covid pandemic are developing the UK's first bubonic ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...

The team behind the Oxford AstraZeneca covid vaccine say they are developing an injection that could prevent the bubonic ...